164 filings
6-K
GLMD
Galmed Pharmaceuticals Ltd
19 Mar 24
Current report (foreign)
4:30pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
15 Mar 24
Current report (foreign)
9:13am
6-K
GLMD
Galmed Pharmaceuticals Ltd
22 Nov 23
Current report (foreign)
4:05pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
20 Nov 23
Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
4:37pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
26 Sep 23
Galmed Announces Allowance of New Patent for Aramchol for the Treatment of Pulmonary and Dermal Fibrosis
8:51am
6-K
ycdj4gr6z8q3ut
22 Sep 23
Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification
4:15pm
6-K/A
n9jzimef
21 Sep 23
Current report (foreign) (amended)
7:30am
6-K
30861eq7
20 Sep 23
Current report (foreign)
4:30pm
6-K
p3vfk5301
13 Sep 23
Current report (foreign)
4:01pm
6-K
je4iqhh6dsoj 14
9 Aug 23
Current report (foreign)
4:43pm
6-K
p8716vl c5j6
9 Aug 23
Current report (foreign)
4:30pm
6-K
dbpk ham4lxneyaw0d
2 Aug 23
Consolidated Financial Statements
4:30pm
6-K
wmxul
18 Jul 23
Current report (foreign)
9:25am
6-K
57e88df 5nqbh8hot
14 Jul 23
Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering
9:44am
6-K
l54y x72cc
10 Jul 23
Current report (foreign)
8:10am
6-K
ilz3l2vs5zh f6n21zps
1 Jun 23
Galmed Pharmaceuticals Reports First Quarter 2023 Financial Results
8:14am
6-K
kxzxleos9lelb n8
12 May 23
Current report (foreign)
7:00am
6-K
gp1x911
11 May 23
Current report (foreign)
4:15pm
6-K
41eovumq rb
9 May 23
Current report (foreign)
7:14am
6-K
kfgaw zp8u339cz70y66
4 May 23
Current report (foreign)
4:15pm